8-K: Edgewell Personal Care Reports Mixed Q3 Results, Raises Full-Year Adjusted EPS and EBITDA Outlook
Quarterly Report
Edgewell Personal Care's third quarter saw a slight decrease in net sales but significant gross margin expansion, leading to an increase in adjusted earnings per share and an updated full-year outlook.
Summary
- Edgewell Personal Care reported a net sales decrease of 0.3% to $647.8 million in the third quarter of fiscal year 2024.
- Organic net sales, which exclude currency impacts, increased by 0.6%.
- GAAP diluted earnings per share (EPS) decreased by 4% to $0.98, while adjusted EPS increased by 23% to $1.22.
- The company ended the quarter with $196.1 million in cash and access to a $369.7 million revolving credit facility.
- Edgewell returned $17.4 million to shareholders through share repurchases and dividends.
- The board declared a cash dividend of $0.15 per common share.
- The company is now projecting full-year sales growth of about 1%, slightly below previous forecasts.
- However, the full-year projections for adjusted EPS and EBITDA have been increased.
- Adjusted gross margin increased by 160 basis points due to cost productivity and strategic revenue management.
- The company incurred $4.9 million in pre-tax restructuring and repositioning expenses, a $2.5 million charge related to a legal matter, and $0.7 million in acquisition and integration costs related to the Billie acquisition.
- Adjusted EBITDA was $117.2 million, compared to $109.7 million in the prior year quarter.
- Net cash provided by operating activities was $157.3 million for the nine months ending June 30, 2024, compared to $168.3 million in the prior year period.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the increase in adjusted EPS and EBITDA guidance, along with strong gross margin expansion. However, the slight decrease in net sales and challenges in some segments temper the overall positive outlook.
Positives
- Organic net sales showed growth of 0.6%, indicating underlying strength in the business.
- Adjusted EPS increased by 23%, demonstrating improved profitability.
- Adjusted gross margin expanded by 160 basis points, driven by cost productivity and revenue management.
- The company increased its full-year projections for adjusted EPS and EBITDA.
- The company has a strong cash position with $196.1 million on hand and access to a revolving credit facility.
- The company returned capital to shareholders through share repurchases and dividends.
- International businesses sustained their momentum, achieving significant growth through a balanced mix of pricing and volume improvements.
- The Sun and Skin Care segment saw a 4.9% increase in net sales, driven by Sun Care and Grooming.
Negatives
- Net sales decreased by 0.3% compared to the prior year quarter.
- GAAP diluted EPS decreased by 4% compared to the prior year quarter.
- North America Wet Shave and Feminine Care segments experienced declines.
- Advertising and sales promotion expenses decreased by $3.4 million, which may impact future sales.
- Selling, general and administrative expenses increased as a percentage of net sales.
- The company lowered its full-year organic net sales growth outlook from 2% to approximately 1%.
- The Feminine Care segment saw a 7.9% decrease in net sales and a 52.9% decrease in segment profit.
Risks
- The company faces a competitive and dynamic market landscape.
- Currency movements had an unfavorable impact on net sales and earnings.
- Weak category and channel dynamics in North America, particularly in the drug channel, impacted sales.
- The company is incurring restructuring and repositioning charges, which may impact short-term profitability.
- The company is facing a legal matter charge of $2.5 million.
- The company is experiencing declines in the North America Wet Shave and Feminine Care segments.
- The company is experiencing higher people expenses and legal costs.
Future Outlook
The company anticipates concluding the year with sales growth of about 1%, slightly below previous forecasts, but is increasing its full-year projections for adjusted EPS to approximately $3.00 and adjusted EBITDA to approximately $356 million.
Management Comments
- Our third quarter results reflected robust gross margin accretion leading to substantial adjusted EBITDA and earnings per share growth.
- Amidst a competitive and dynamic market landscape, organic net sales growth featured continued strength in our Right-to-Win portfolio, propelled by our industry-leading Sun Care and Grooming businesses.
- Our international businesses sustained their momentum, achieving significant growth through a balanced mix of pricing and volume improvements.
- Crucially, we achieved over 160-basis points of adjusted gross margin accretion, driven by our steadfast commitment to cost productivity and strategic revenue management initiatives.
- Reflecting on our performance to date, while we now anticipate concluding the year with sales growth of about 1% and slightly below our previously forecasted range, we are increasing our full year projections for adjusted EPS and EBITDA.
- Our transformation that began just over three years ago continues to yield positive results.
- In order to accelerate our progress across key priorities, we announced, in a separate press release today, key changes to enhance our leadership team and simplify our operating model.
- I'm confident that these changes will strengthen our business and better position Edgewell for sustainable top and bottom-line growth.
Industry Context
The results reflect a mixed performance in the consumer products sector, with some segments showing strength while others face challenges. The company's focus on cost productivity and strategic revenue management aligns with industry trends aimed at improving profitability in a competitive environment. The leadership changes also indicate a proactive approach to adapting to market dynamics.
Comparison to Industry Standards
- Edgewell's adjusted gross margin increase of 160 basis points is a positive sign, indicating effective cost management and pricing strategies, which is a key focus for consumer goods companies.
- The company's performance in the Sun Care segment, with a 4.9% increase in net sales, is notable, as this segment is often seasonal and can be impacted by weather patterns, similar to other companies in the personal care space such as Unilever and Proctor & Gamble.
- The decline in the Feminine Care segment is a concern, as this is a competitive market with established players like Kimberly-Clark and P&G, and Edgewell will need to address the issues in this segment to maintain overall growth.
- The company's adjusted EPS growth of 23% is a strong performance, indicating effective cost control and operational improvements, which is a key metric for investors in the consumer goods sector.
- The company's net debt leverage ratio of 3.1x is within a reasonable range for the industry, but it will be important to monitor this metric going forward, especially with the planned restructuring and repositioning actions.
Legal Proceedings
- The company recorded a charge of $2.5 million related to a legal matter.
Stakeholder Impact
- Shareholders will benefit from increased adjusted EPS and EBITDA guidance, as well as continued dividends and share repurchases.
- Employees may be impacted by the restructuring and repositioning actions.
- Customers may see changes in product offerings and promotions.
- Suppliers may be impacted by changes in the company's supply chain.
- Creditors will be interested in the company's debt levels and cash flow.
Next Steps
- The company will continue to focus on cost productivity and strategic revenue management.
- The company will implement key changes to enhance the leadership team and simplify the operating model.
- The company will continue to monitor and address the challenges in the North America Wet Shave and Feminine Care segments.
- The company will continue to execute its share repurchase program.
Key Dates
| Date | Description |
|---|---|
| August 6, 2024 | Date of the earnings release and declaration of a cash dividend. |
| June 30, 2024 | End of the third fiscal quarter 2024. |
| September 4, 2024 | Record date for the declared cash dividend. |
| October 3, 2024 | Payment date for the declared cash dividend. |
Keywords
Edgewell Personal Care, Net Sales, Organic Sales, Gross Margin, Adjusted EPS, EBITDA, Share Repurchases, Dividends, Wet Shave, Sun Care, Feminine Care, Restructuring, Consumer Products
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.